Credit Suisse’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

Credit Suisse’s Portfolio BCEL Stock Details BCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14	Closed	–	–	4400
2022 Q2	$0	Buy	+14	New	+$29	﹤0.01%	4455
2021 Q4	–	Sell	-18,553	Closed	-$115K	–	4709
2021 Q3	$115K	Buy	18,553 +255	+1%	+$1.7K	﹤0.01%	4308
2021 Q2	$156K	Sell	18,298 -872	-5%	-$8.93K	﹤0.01%	4323
2021 Q1	$294K	Sell	19,170 -26,272	-58%	-$427K	﹤0.01%	4003
2020 Q4	$733K	Buy	45,442 +22,469	+98%	+$337K	﹤0.01%	3568
2020 Q3	$321K	Buy	+22,973	New	+$343K	﹤0.01%	3621

Other funds holding BCEL

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return